Archives

by in
Entry Author Date Location
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Melinta Therapeutics Obtains $70,000,000 Series C Round 02/10/14 Boston
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing 11/29/12 Boston
Rib-X Pharmaceuticals Lands Series B Financing Round 11/29/12 Boston
Pearl Therapeutics Secures $65,000,000 Series D Round 11/13/12 San Francisco
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Kinvey, Zink, ImmusanT, and More of this Week’s Boston Dealmakers 12/14/11 Boston
ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A 12/13/11 Boston
ImmusanT Secures $20,000,000 Series A Round 12/13/11 Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial 12/01/10 San Francisco
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News 10/22/10 San Francisco
Pearl Therapeutics Gets $69M 10/19/10 San Francisco
Pearl Therapeutics Receives $69,000,000 Series C Financing Round 10/19/10 San Francisco
Page 1 of 1